Epica International, Inc. Secures $18 Million Growth Capital Credit Facility From Avenue Capital Group to Drive Innovation and Expansion
Summary
"We are excited to partner with Epica International and support their mission to revolutionize medical imaging and robotics," said Chad Norman, Senior Portfolio Manager at Avenue Capital. "Epica Internationals advanced medical imaging and precision robotics solutions are used in a wide range of applications, including human and animal healthcare and research. The companys patented technologies enhance user accuracy and outcomes, enabling clinicians and researchers to achieve new levels of precision and efficiency. By combining advanced automation with precision engineering, the company empowers manufacturers to enhance efficiency, accuracy, and overall production quality.This strategic financing aligns with a broader industry trend toward increased investment in medical technology innovation, particularly in areas such as minimally invasive surgery, image-guided therapy, and artificial intelligence-powered diagnostics. For more information on Epica International, please visit our website at www.epicainternational.comThe Avenue Venture Debt Funds seek to provide creative financing solutions to high-growth, venture capital-backed technology and life science companies, focusing generally on companies within the underserved segment of the market created by the widening financing gap between commercial banks and larger debt funds.